mRNA Vaccines against Flaviviruses

被引:29
|
作者
Wollner, Clayton J. [1 ]
Richner, Justin M. [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
flavivirus; mRNA vaccines; Dengue; Zika; tick-borne encephalitis;
D O I
10.3390/vaccines9020148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous vaccines have now been developed using the mRNA platform. In this approach, mRNA coding for a viral antigen is in vitro synthesized and injected into the host leading to exogenous protein expression and robust immune responses. Vaccines can be rapidly developed utilizing the mRNA platform in the face of emerging pandemics. Additionally, the mRNA coding region can be easily manipulated to test novel hypotheses in order to combat viral infections which have remained refractory to traditional vaccine approaches. Flaviviruses are a diverse family of viruses that cause widespread disease and have pandemic potential. In this review, we discuss the mRNA vaccines which have been developed against diverse flaviviruses.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] Development of Antibody Therapeutics against Flaviviruses
    Sun, Haiyan
    Chen, Qiang
    Lai, Huafang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [32] The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
    Jamous, Yahya F.
    Alhomoud, Dalal A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [33] Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
    Martinez, David R.
    Schafer, Alexandra
    Leist, Sarah R.
    De la Cruz, Gabriela
    West, Ande
    Atochina-Vasserman, Elena N.
    Lindesmith, Lisa C.
    Pardi, Norbert
    Parks, Robert
    Barr, Maggie
    Li, Dapeng
    Yount, Boyd
    Saunders, Kevin O.
    Weissman, Drew
    Haynes, Barton F.
    Montgomery, Stephanie A.
    Baric, Ralph S.
    SCIENCE, 2021, 373 (6558) : 991 - +
  • [34] Modified mRNA-Based Vaccines Against Coronavirus Disease 2019
    Wang, Aline Yen Ling
    CELL TRANSPLANTATION, 2022, 31
  • [35] Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer
    Meulewaeter, Sofie
    Zhang, Yao
    Wadhwa, Abishek
    Fox, Kevin
    Lentacker, Ine
    Harder, Kenneth W.
    Cullis, Pieter R.
    De Smedt, Stefaan C.
    Cheng, Miffy H. Y.
    Verbeke, Rein
    JOURNAL OF MOLECULAR BIOLOGY, 2024, 436 (02)
  • [36] SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
    McGuiness, James
    Weidert, Frances
    DeVries, Anna
    Ligon, John
    Zhang, Dingpeng
    Von Roemeling, Christina
    Grippin, Adam
    Karachi, Aida
    Qdaisat, Sadeem
    Thomas, Nagheme
    Castillo, Paul
    Huang, Jianping
    Silver, Natalie
    Rahman, Maryam
    Hwang, Eugene
    Mitchell, Duane
    Mendez-Gomez, Hector
    Sayour, Elias
    NEURO-ONCOLOGY, 2023, 25
  • [37] mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
    Echaide, Miriam
    de Erauso, Luisa Chocarro
    Bocanegra, Ana
    Blanco, Ester
    Kochan, Grazyna
    Escors, David
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [38] Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
    Lim, Wey Wen
    Mak, Loretta
    Leung, Gabriel M.
    Cowling, Benjamin J.
    Peiris, Malik
    LANCET MICROBE, 2021, 2 (09): : E423 - E423
  • [39] Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses
    Harrison, Jessica J.
    Hobson-Peters, Jody
    Bielefeldt-Ohmann, Helle
    Hall, Roy A.
    VACCINES, 2021, 9 (11)
  • [40] mRNA as a Therapeutics: Understanding mRNA Vaccines
    Oguz, Ferdi
    Atmaca, Harika
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (02) : 274 - 282